Some clinical studies have shown that IL-6, like many other proinflammatory cytokines, increases in patients with pulmonary arterial hypertension and is associated with hazard of death118,159,236,237; though the French Network of Pulmonary Hypertension suggests that IL-6 was not significantly associated with increased hazard of death159. Here, IL6 is linked to pulmonary arterial hypertension.